8.35
-0.22
(-2.52%)
At close: 3:29:02 PM GMT+2
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
3/31/2021
Operating Cash Flow
-775,343
-765,268
-843,393
-677,729
-552,138
Investing Cash Flow
-2,833,557
5,203,623
-44,269
303,295
-31,702
Financing Cash Flow
-1,075,265
419,364
499,462
306,792
456,264
End Cash Position
2,001,293
6,550,450
1,692,115
2,074,034
2,141,676
Income Tax Paid Supplemental Data
--
12,354
5,128
916
4,076
Interest Paid Supplemental Data
--
10,268
5,303
5,535
2,017
Capital Expenditure
-4,137
-1,382
-12,690
-17,436
-5,806
Issuance of Capital Stock
--
438,555
379,708
--
455,756
Issuance of Debt
--
--
159,899
36,400
--
Repayment of Debt
-60,418
-30,705
-30,144
-21,590
--
Free Cash Flow
-779,480
-766,650
-856,083
-695,165
-557,944
3/31/2021 - 10/8/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
300871.SZ Hvsen Biotechnology Co., Ltd.
27.02
+0.97%
SOFTX.OL SoftOx Solutions AS
0.0588
+26.18%
SBTX.L SkinBioTherapeutics plc
19.25
-0.65%
OCS Oculis Holding AG
16.75
+3.72%
SANN.SW Santhera Pharmaceuticals Holding AG
12.82
-3.32%
OXB.L Oxford Biomedica plc
279.00
+0.18%
KAPA Kairos Pharma, Ltd.
1.0100
+2.02%
SLXN Silexion Therapeutics Corp
0.8450
+2.55%
PRTG Portage Biotech Inc.
8.59
+70.44%
MESO Mesoblast Limited
10.14
-2.50%